| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/01/2006 | EP1630235A2 Compounds for immunodiagnosis of prostate cancer and method for their use |
| 03/01/2006 | EP1630230A2 Streptococcus pneumoniae proteins and nucleic acids |
| 03/01/2006 | EP1630229A2 Melanoma antigens |
| 03/01/2006 | EP1630175A1 Antibodies directed against Marburg I polymorphism of factor VII activating protease (FSAP), production and use thereof |
| 03/01/2006 | EP1630172A2 A method for identification, isolation and production of antigens to a specific phathogen |
| 03/01/2006 | EP1630168A2 Molecular mimetics of meningococcal B peptides |
| 03/01/2006 | EP1629275A2 Method for the selection of epitopes for immunotherapy |
| 03/01/2006 | EP1629106A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 03/01/2006 | EP1629095A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/01/2006 | EP1629014A2 Polypeptides that bind an anti-tissue factor antibody and uses thereof |
| 03/01/2006 | EP1629013A1 Pharmaceutical composition comprising a bispecific antibody specific for epcam |
| 03/01/2006 | EP1629012A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 03/01/2006 | EP1629011A2 Human-anti-human cd3 binding molecules |
| 03/01/2006 | EP1629010A1 Treatment with anti-vegf antibodies |
| 03/01/2006 | EP1629009A1 Compositions comprising large and small binding fragments of antibodies against the same toxin |
| 03/01/2006 | EP1629008A1 Tnf-like secreted protein |
| 03/01/2006 | EP1629005A2 Enterococcus antigens |
| 03/01/2006 | EP1629002A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 03/01/2006 | EP1629001A2 Blys antagonists and uses thereof |
| 03/01/2006 | EP1628991A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 03/01/2006 | EP1628679A2 Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| 03/01/2006 | EP1628675A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 03/01/2006 | EP1628631A2 Methods of treating hyperproliferative cell disorders |
| 03/01/2006 | EP1628530A2 Methods and compositions for the prevention and treatment of sepsis |
| 03/01/2006 | EP1563084A4 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 03/01/2006 | EP1542731A4 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 03/01/2006 | EP1305636B1 Screening method |
| 03/01/2006 | EP1305421B1 Enhanced 2-keto-l-gulonic acid production |
| 03/01/2006 | EP1062517B1 Diagnosis of spongiform encephalopathies using prionins |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0981364B1 Method and compositions for treating hyperlipidemia |
| 03/01/2006 | EP0956506B1 Treatment and diagnosis of cancer |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | EP0914346B1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCalpha RECEPTOR ANTIBODIES |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0859833B1 Recombinant hepatitis c virus rna replicase |
| 03/01/2006 | EP0840750B1 Ha-2 antigenic peptide |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | CN1742083A Immunizing fish against viral infection |
| 03/01/2006 | CN1742022A Neuropilin-1 inhibitors |
| 03/01/2006 | CN1742021A Therapeutic human anti-IL-1R1 monoclonal antibody |
| 03/01/2006 | CN1243830C Novel mouse CXC chemotactic receptor |
| 03/01/2006 | CN1243771C Novel alginate monoclonal antibody and its preparation method and use |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 02/28/2006 | US7005814 Motor control apparatus having current supply phase correction |
| 02/28/2006 | US7005560 Transgenic plants expressing assembled secretory antibodies |
| 02/28/2006 | US7005510 Recombinant DNase B derived from Streptococcus pyogenes |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005504 Antiinflammatory agents |
| 02/28/2006 | US7005503 High throughput screening of antibody libraries against membrane proteins; chemokines; infection inhibition |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005498 analogues of immunogenic human Her2 proteins comprising amino acid sequences modified foreign T-helper lymphocyte epitopes, used for immunotherapy |
| 02/28/2006 | US7005413 Administering an interleukin-1 (IL-1) inhibitor, a Tumor Necrosis Factor (TNF)-alpha inhibitor such as etanercept, and an Osteoprotegerin (OPG) protein of given amino acid sequence; osteoporosis |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7005276 missense mutagenesis; blood testing; host cells; kits |
| 02/28/2006 | US7005270 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 02/28/2006 | US7005269 ERAAP modulators regulate immune responses |
| 02/28/2006 | CA2486285A1 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 02/24/2006 | CA2516876A1 Antibodies which are directed against the marburg i polymorphism of factor vii-activating protease (fsap), and their preparation and use |
| 02/23/2006 | WO2006020706A2 Tie complex binding proteins |
| 02/23/2006 | WO2006020498A2 Therapeutic agents and methods for cardiovascular disease |
| 02/23/2006 | WO2006020263A2 Cytoxan antibodies and immunoassay |
| 02/23/2006 | WO2006019447A1 Optimized fc variants |
| 02/23/2006 | WO2006019192A1 POLYPEPTIDE HAVING ACTIVITY OF UNSATURATING ω3-FATTY ACID, POLYNUCLEOTIDE CODING FOR THE POLYPEPTIDE AND USE THEREOF |
| 02/23/2006 | WO2006019153A1 NONHUMAN ANIMAL WITH INHIBITED GdsmA GENE FUNCTION AND PROMOTED OR INHIBITIED CANCERATION-ASSOCIATED GENE FUNCTION |
| 02/23/2006 | WO2006018429A1 Multimers of peptides |
| 02/23/2006 | WO2006017961A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 02/23/2006 | WO2005110475A3 Antibodies |
| 02/23/2006 | WO2005080429A3 Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies |
| 02/23/2006 | WO2005064021A3 Vaccine |
| 02/23/2006 | WO2005058815A3 Ip-10 antibodies and their uses |
| 02/23/2006 | WO2005028666A3 Determining kinase specificity |
| 02/23/2006 | WO2005028497A3 Receptor binding peptides derived from the sars s protein |
| 02/23/2006 | WO2004108885A3 Fc chimeric proteins with anti-hiv drugs |
| 02/23/2006 | WO2004078137A3 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2004045553A3 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 02/23/2006 | WO2003070889A3 Prostate specific genes and the use thereof in design or therapeutics |
| 02/23/2006 | US20060041947 Nessie nucleic acids, polypeptides and mutations, and methods of use thereof |
| 02/23/2006 | US20060041106 Apo-3 polypeptide |
| 02/23/2006 | US20060041058 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 02/23/2006 | US20060040883 Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040372 GANP protein |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040363 Human antibodies derived from immunized xenomice |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040354 Novel polyadenylation signal for use in expression vectors |
| 02/23/2006 | US20060040325 Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity |
| 02/23/2006 | US20060040323 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040306 81588 methods and compositions of human proteins and uses thereof |
| 02/23/2006 | US20060040302 Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors |
| 02/23/2006 | US20060040298 Rhesus monkey NURR1 nuclear receptor |
| 02/23/2006 | US20060040285 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 02/23/2006 | US20060040278 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer |
| 02/23/2006 | US20060040267 Transcriptional activator |